Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PF-08653944 in healthy Chinese adults with overweight or obesity
NCT07845513Phase 1Not yet recruiting
- Sponsor
- Pfizer
- Start
- Nov 2026
- Primary completion
- Feb 2027
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of PF-08653944 in heart failure (HF), sponsored by Pfizer. Primary endpoints: Area Under the Concentration Versus Time Curve at 85 days and Maximum Observed Concentration at 85 days. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
PF-08653944
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT07845513.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07845513.